Answers are grounded in this paper and cite their sources.
The present study provides evidence of increasing levels of evidence for published clinical trials on urolithiasis in 2014 (as compared with earlier data). Ninety percent of publications indicated conflicts of interest, whereas sponsoring of studies was declared only by one-third. A considerable number of trials involved issues of high commercial impact. Recently established legal programmes and voluntary acts on self-reporting of financial relationships will enhance transparency in the future; however, increased public funding will be needed to further promote the quality of trials on urolithiasis.
No takes yet. Share an insight, caveat, or question.
Schoenthaler et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: